Medicina
Departamento
Stanford University
Stanford, Estados UnidosPublicaciones en colaboración con investigadores/as de Stanford University (55)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Comparison of the Accuracy of the 7-Item HADS Depression Subscale and 14-Item Total HADS for Screening for Major Depression: A Systematic Review and Individual Participant Data Meta-Analysis
Psychological Assessment, Vol. 35, Núm. 2, pp. 94-114
-
Omalizumab in IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 4, pp. 1134-1146
-
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience
Clinical Genitourinary Cancer, Vol. 21, Núm. 5, pp. 584-593
-
The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
The Lancet Rheumatology, Vol. 5, Núm. 8, pp. e451-e460
-
WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)
World Allergy Organization Journal, Vol. 16, Núm. 3
2022
-
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
Clinical Genitourinary Cancer, Vol. 20, Núm. 5, pp. e440-e452
-
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer
BJU International, Vol. 130, Núm. 5, pp. 592-603
-
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma
Clinical Genitourinary Cancer, Vol. 20, Núm. 6, pp. 558-567
-
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Scientific Data, Vol. 9, Núm. 1
-
Long-term disease control and safety with the anti-CCR4 antibody mogamulizumab: Post-hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T-cell lymphoma
Dermatologic Therapy
-
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
Blood, Vol. 140, Núm. 5, pp. 419-437
-
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin
Clinical Genitourinary Cancer, Vol. 20, Núm. 2, pp. 165-175
2021
-
Consensus on DEfinition of Food Allergy SEverity (DEFASE) an integrated mixed methods systematic review
World Allergy Organization Journal, Vol. 14, Núm. 3
-
Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study
Journal of Psychosomatic Research, Vol. 140
-
Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEMINI-2 clinical studies
HIV Research and Clinical Practice, Vol. 23, Núm. 1, pp. 9-14
-
The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial
Trials, Vol. 22, Núm. 1
-
Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study*
British Journal of Dermatology, Vol. 184, Núm. 4, pp. 722-730
-
Worldwide Survey of COVID-19-Associated Arrhythmias
Circulation: Arrhythmia and Electrophysiology, Vol. 14, Núm. 3, pp. E009458
2020
-
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
The Lancet, Vol. 395, Núm. 10241, pp. 1907-1918